MDA Space

Goeasy and Propel stocks are undervalued due to macroeconomic fears, but their fundamentals are strong, presenting a significant rebound opportunity. Zedcor's US expansion and new product success indicate robust growth potential, making it an attractive buy on pullbacks. VitalHub's recent acquisition and organic growth in healthcare data reporting position it for significant short, medium, and long-term gains.» Mehr auf seekingalpha.com

Vertical integration of SatixFy expected to further enhance the MDA Space end-to-end satellite offering as demand for digital constellations grows MDA Space to pay US$2.10 per SatixFy share, representing a 75% premium to SatixFy's share price on March 31, 2025 BRAMPTON, ON and REHOVOT, Israel, April 1, 2025 /PRNewswire/ - MDA Space Ltd. (TSX: MDA), a trusted mission partner to the rapidly expanding global space industry, and SatixFy Communications Ltd.» Mehr auf prnewswire.com

Ifetroban demonstrated significant 5.4% improvement in cardiac function NASHVILLE, Tenn. , March 19, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on rare diseases, today announced that results from its Phase 2 FIGHT DMD clinical trial were selected for a late-breaking presentation at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference in Dallas.» Mehr auf prnewswire.com